glp-1 where to inject How To: Use Injections The most recommended injection sites

Food and Drug Administration: (May 2022) Approved as adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus (November 2023) Approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity (December 2024) Expanded indication for moderate-to-severe obstructive sleep apnea in adults with obesity Classified as first-in-class dual GIP/GLP-1 receptor agonist Not approved for type 1 diabetes mellitus or as monotherapy in patients with history of pancreatitis International Regulatory Approvals GLP2 has received regulatory approval in multiple jurisdictions: European Union (September 2022) Type 2 diabetes treatment United Kingdom (November 2023) Expanded to include weight management Canada (November 2022) Type 2 diabetes indication Australia (December 2022) Type 2 diabetes treatment Additional regulatory reviews ongoing in other countries Warnings and Contraindications Important safety considerations include: Boxed Warning for thyroid C-cell tumor risk (based on rodent studies

Unlike the injectables, which enter the bloodstream directly, the pills are broken down in the stomach, which means the oral doses have to be much, much higher than the Wegovy injections, which cap at 2.4 mg, McCoy explains

(The number of prescriptions exceeds the number of patients because prescription refills and renewals are counted separately.) Another indication of weight-loss drugs rapid uptake globally comes from the financial statements of their manufacturers

How long do the effects of a Vitamin B12 Shot last